The afore-mentioned treatments increase the pulmonary expression of IL-1β, TNFα, IL-6 in BLM-induced lung fibrosis (Sriram et al., 2009; Tang et al., 2016; Yan et al., 2017) and in PRQ induced lung fibrosis in mice (He et al., 2012). The gene discussed is TNF; the disease is pulmonary fibrosis.